Discovering and Characterizing of Survivin Dominant Negative Mutants With Stronger Pro-apoptotic Activity on Cancer Cells and CSCs
Survivin as a member of the inhibitor of apoptosis proteins (IAPs) family is undetectable in normal cells, but highly expressed in cancer cells and cancer stem cells (CSCs) which makes it an attractive target in cancer therapy. Survivin dominant negative mutants have been reported as competitive inh...
Main Authors: | Wei Guo, Xingyuan Ma, Yunhui Fu, Chang Liu, Qiuli Liu, Fabiao Hu, Hui Miao, Tong Zhang, Yuping Liu, Myong Hun Han, Fang You, Yi Yang, Wenyun Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.635233/full |
Similar Items
-
MiRNA-mediated EMT and CSCs in cancer chemoresistance
by: Bing Dong, et al.
Published: (2021-02-01) -
Addressing the Needs of the Whole Child: What Public Health Can Do to Answer the Education Sector’s Call for a Stronger Partnership
by: Diane Allensworth, PhD, et al.
Published: (2011-03-01) -
A nanobody-based molecular toolkit for ubiquitin–proteasome system explores the main role of survivin subcellular localization
by: Hui Miao, et al.
Published: (2023-01-01) -
Survivin Small Molecules Inhibitors: Recent Advances and Challenges
by: Najah Albadari, et al.
Published: (2023-02-01) -
ABC transporters in CSCs membranes as a novel target for treating tumour relapse
by: LAURA eZINZI, et al.
Published: (2014-07-01)